Receptor epitope usage by an interleukin-5 mimetic peptide.
about
Asymmetric usage of antagonist charged residues drives interleukin-5 receptor recruitment but is insufficient for receptor activationThe GM-CSF/IL-3/IL-5 cytokine receptor family: from ligand recognition to initiation of signaling.Interleukin-5 receptor subunit oligomerization and rearrangement revealed by fluorescence resonance energy transfer imagingMolecular and clinical rationale for therapeutic targeting of interleukin-5 and its receptor.
P2860
Receptor epitope usage by an interleukin-5 mimetic peptide.
description
2005 nî lūn-bûn
@nan
2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Receptor epitope usage by an interleukin-5 mimetic peptide.
@ast
Receptor epitope usage by an interleukin-5 mimetic peptide.
@en
type
label
Receptor epitope usage by an interleukin-5 mimetic peptide.
@ast
Receptor epitope usage by an interleukin-5 mimetic peptide.
@en
prefLabel
Receptor epitope usage by an interleukin-5 mimetic peptide.
@ast
Receptor epitope usage by an interleukin-5 mimetic peptide.
@en
P2093
P2860
P356
P1476
Receptor epitope usage by an interleukin-5 mimetic peptide.
@en
P2093
Cecilia Urbina
Dominick Panarello
Irwin Chaiken
Madhushree Bhattacharya
Tetsuya Ishino
P2860
P304
22951-22961
P356
10.1074/JBC.M502341200
P407
P577
2005-04-12T00:00:00Z